Syringes & Needles are Gaining Traction Owing to Global Burden of Chronic Diseases
The market for syringes and needles is expanding as a result of factors such the high and rising burden of infectious and chronic diseases, the increased use of injectable drugs and technological breakthroughs achieved by medical device firms in syringes. The global burden of chronic diseases like cancer, cardiovascular disease and diabetes is increasing. Cancer is a serious disease that affects the entire world's population. According to the American Cancer Society, in the United States, 1.9 million new cancer cases and 609,820 cancer deaths were projected in 2023. The global burden of cancer is anticipated to rise to 27.5 million new cases by 2040. The rising number of cancer patients generate demand for syringes and needles for medication administration, which is likely to considerably contribute to the market's growth throughout the forecast period. Market participants' new product launches are expected to contribute to the growth of the market.
Furthermore, the increase in worldwide vaccination initiatives is a crucial factor in the syringe and needle market. The extensive distribution of vaccines for various infections, flu, and other diseases, requires a significant rise in syringe and needle manufacturing and delivery. Every vaccination necessitates specific, disposable syringes in order to guarantee safety and effectiveness, resulting in increased need in different healthcare environments. Additionally, continued vaccination efforts and the administration of booster doses are increasing the demand for dependable, sterile injection equipment. The ability for syringe production to expand and adjust to these needs is essential, as it plays a key role in supporting public health efforts and driving market growth and innovation in medical injection technology.
Furthermore, the increase in worldwide vaccination initiatives is a crucial factor in the syringe and needle market. The extensive distribution of vaccines for various infections, flu, and other diseases, requires a significant rise in syringe and needle manufacturing and delivery. Every vaccination necessitates specific, disposable syringes in order to guarantee safety and effectiveness, resulting in increased need in different healthcare environments. Additionally, continued vaccination efforts and the administration of booster doses are increasing the demand for dependable, sterile injection equipment. The ability for syringe production to expand and adjust to these needs is essential, as it plays a key role in supporting public health efforts and driving market growth and innovation in medical injection technology.
Geriatric Population & Government Initiatives Are Key Growth Factors in The Industry
According to the World Health Organization, approximately 1.4 billion people globally will be over 60 by 2030. The rising frequency of several chronic diseases, as well as the growing number of hospitals and clinics in developing countries, are also projected to drive the needles market over the forecast period. As stated by the Centres for Disease Control and Prevention (CDC), six out of ten People have at least one chronic disease. Furthermore, the advancement of needle technology reduces the anxiety and pain associated with injections. Pain and anxiety are treated with specific treatment regimens in which various psychological and physical factors trigger pain receptors in the brain.
For instance, there is a strong correlation between dental injection and pain and anxiety during dental operations. Also, rising blood donation awareness is projected to boost market growth in the near future. Voluntary blood donation can help to supplement the blood supply, boosting demand for needles and syringes. Strict laws in many developed countries, such as Europe, have resulted in required blood test donations for HIV and HBV infections. As a result, the usage of needles for blood donation and testing has skyrocketed in recent years. Furthermore, The American National Red Cross reports that demand for blood and other blood-related products is high due to an increase in complex therapies like heart surgery, chemotherapy and organ transplantation, all of which require large number of these products.
For instance, there is a strong correlation between dental injection and pain and anxiety during dental operations. Also, rising blood donation awareness is projected to boost market growth in the near future. Voluntary blood donation can help to supplement the blood supply, boosting demand for needles and syringes. Strict laws in many developed countries, such as Europe, have resulted in required blood test donations for HIV and HBV infections. As a result, the usage of needles for blood donation and testing has skyrocketed in recent years. Furthermore, The American National Red Cross reports that demand for blood and other blood-related products is high due to an increase in complex therapies like heart surgery, chemotherapy and organ transplantation, all of which require large number of these products.
Recent Trends in Syringes and Needles Market:
- Increased use of prefilled syringes enhances medication safety and convenience for patients
- Advancements in needle technology aim to reduce pain and improve patient comfort during injections
- Growth in chronic disease management drives demand for advanced syringes and needle systems
- Expansion of vaccination programs boosts market growth and encourages syringe and needle development
Explore Our Breakthrough Market Segmentation and Personalize it to Meet Your Business Needs…!
Needlestick Injuries & Product Recall May Limit Market Growth
With several market drivers, there are also a few restrictions preventing the sector from reaching its full potential. The use of syringes and needles increases the risk of infection. Every year, roughly 385,000 people are injured by infected needles and other sharps devices, according to the CDC. Drug delivery via syringes and needles can sometimes cause adverse reactions in some patients, which is likely one of the biggest syringes and needle market limitations. The syringe and needle market participants are attempting to deal with and overcome these obstacles in order to reduce market gaps.
However, Challenges in quality control and recalls caused by defects or contamination can undermine consumer trust and disrupt the market. If syringes and needles encounter problems like sterilization issues or material defects, it not only impacts patient safety but also causes major interruptions in supply chains. These issues can lead to expensive product recalls and harm the reputation of a brand, ultimately affecting market stability and consumer confidence in the dependability of medical products. For instance, in June, Cardinal Health is expanding their previous product correction actions to a product removal of Cardinal Health brand Monoject sterile Luer-Lock Soft Pack Syringes (1, 3, 6, 12, 20, 35, and 60 mL) and Cardinal Health brand Monoject sterile Enteral Syringes with the ENFit connection (1, 3, 6, 12, 35, and 60 mL) due to a change in manufacturing and rebranding efforts.
However, Challenges in quality control and recalls caused by defects or contamination can undermine consumer trust and disrupt the market. If syringes and needles encounter problems like sterilization issues or material defects, it not only impacts patient safety but also causes major interruptions in supply chains. These issues can lead to expensive product recalls and harm the reputation of a brand, ultimately affecting market stability and consumer confidence in the dependability of medical products. For instance, in June, Cardinal Health is expanding their previous product correction actions to a product removal of Cardinal Health brand Monoject sterile Luer-Lock Soft Pack Syringes (1, 3, 6, 12, 20, 35, and 60 mL) and Cardinal Health brand Monoject sterile Enteral Syringes with the ENFit connection (1, 3, 6, 12, 35, and 60 mL) due to a change in manufacturing and rebranding efforts.
Product Innovation by Key Players Boost the Market Expansion
In dynamic markets, it is essential to stay competitive through product innovation and strategic development. Improvements in design, functionality, and materials can meet changing consumer needs and regulatory standards. Investing in research and development and adjusting strategies allows companies to bring advanced solutions to improve performance and safety, meet new market needs, and stand out from rivals. This approach ensures continuous growth, enhances market positioning, and stays in line with industry trends and technological advancements. For instance, in April 2024, JERSEY CITY, N.J., announced exciting updates regarding the Droplet Micron 34G x 3.5mm pen needle from HTL-Strefa, a member of the MTD Group. Droplet Micron has received expanded approval from the US Food & Drug Administration, allowing for broader indications of use and a shift from prescription-only to over-the-counter availability. In addition ,in addition in January 2023, Sharps Technology, Inc. an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, announces the advancement of the Company’s specialized prefillable syringe (“PFS”) system product line, which will be manufactured in collaboration with Nephron Pharmaceuticals at the Inject EZ facility in West Columbia, South Carolina.
Know Your Competitors and Strengthen Market Share Effectively
North America Offers Market Participants a Huge Market Potential
The North American region is likely to dominate, owing primarily to the market in the United States. The rising prevalence of heart disorders, the rising incidence of diabetes and a large number of new product approvals in the region are the primary factors driving the growth of the North American syringes and needles market. Coronary Artery Disease was the most frequent kind of heart disease in the United States, affecting nearly 20.1 million adults over the age of 20. Needles and syringes are crucial parts of CVD treatments and therapy. As a result, the disease's high prevalence is projected to aid market expansion. Diabetes is also prevalent and on the rise in the country. According to the CDC, about 37.3 million people across the country have diabetes. If present trends continue, the region's diabetes population is expected to reach 109 million by 2040. Insulin pens and syringes are used in the treatment of diabetes. As a result, rising diabetes prevalence promotes market expansion. Thus, the market is expected to grow considerably throughout the forecast period due to the increasing prevalence of chronic diseases in the country, as well as product innovations.
Searching for a Country or Region-Specific Report?
Unlock industry complexities with reports crafted for selected countries and regions at Reduced Cost
The report provides a detailed overview of the syringes and needles market insights in regions including North America, Latin America, Europe, Asia-Pacific, Oceania, and the Middle East and Africa. The country-specific assessment for syringes and needles market has been offered for all regional market share, along with forecasts, market scope estimates, price point assessment, and impact analysis of prominent countries and regions. Throughout this market research report, Y-o-Y growth and CAGR estimates are also incorporated for every country and region, to provide a detailed view of the syringes and needles market. These Y-o-Y projections on regional and country-level markets brighten the political, economic and business environment outlook, which are anticipated to have a substantial impact on the growth of the syringes and needles market. Some key country and region included in the syringes and needles market report as follows:
| Regions | Countries |
|---|---|
| North America | United States, Canada |
| Latin America | Brazil, Mexico, Argentina, Colombia, Chile, Rest of Latin America |
| Europe | Germany, United Kingdom, France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Norway, Denmark, Finland, Ireland, Czech Republic, Rest of Europe |
| Asia Pacific | China, India, Japan, South Korea, Australia & New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia Pacific |
| Middle East and Africa | GCC Countries, South Africa, Egypt, Turkey, Morocco, Israel, Iran, Kenya, Nigeria, Rest of MEA |
Syringe and Needle Market Research Report Covers In-depth Analysis on:
- Syringe and needle market detailed segments and segment-wise market breakdown
- Syringe and needle market dynamics (Recent industry trends, drivers, restraints, growth potential, opportunities in syringe and needle industry)
- Current, historical and forthcoming 10 years market valuation in terms of syringe and needle market size (US$ Mn), volume (Units), share (%), Y-o-Y growth rate, CAGR (%) analysis
- Syringe and needle market demand analysis
- Syringe and needle market pricing analysis over forecast period (by key segment and by region)
- Syringe and needle market regional insights with region-wise market breakdown
- Competitive analysis – key companies profiling including their market share, product offerings, and competitive strategies.
- Latest developments and innovations in syringe and needle market
- Regulatory landscape by key regions and key countries
- Supply chain and value chain analysis in syringe and needle market
- Syringe and needle market sales and distribution strategies
- A comprehensive overview of parent market
- A detailed viewpoint on syringe and needle market forecast by countries
- Mergers and acquisitions in syringe and needle market
- Essential information to enhance market position
- Robust research methodology
- Frequently Asked Questions -
What factors are driving the growth of syringes and needles market?
Key drivers include increasing global healthcare expenditure, the prevalence of chronic diseases, growing vaccination initiatives and the rising need for safe and effective drug delivery systems.
What are the key challenges faced by syringes and needles market?
Key challenges include regulatory hurdles, high costs of advanced syringes and the need for constant innovation to meet safety standards and patient needs.
How will technological advancements affect syringes and needles market?
Technological advancements, such as smart syringes and needle-free injection systems, are expected to revolutionize the market by improving safety, accuracy and patient comfort.
How is the demand for safety syringes impacting the market?
The demand for safety syringes is significantly boosting market growth as healthcare providers prioritize reducing needlestick injuries and ensuring better patient outcomes.
